Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
0.6739
-0.1055 (-13.54%)
At close: Oct 3, 2025, 4:00 PM EDT
0.6760
+0.0021 (0.31%)
After-hours: Oct 3, 2025, 7:47 PM EDT
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $132.56 million as of October 3, 2025. Its market cap has increased by 79.57% in one year.
Market Cap
132.56M
Enterprise Value
139.43M
1-Year Change
79.57%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $132.56M, a decrease of -70.32%. That is a compound annual growth rate of -27.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 132.56M | -26.48% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |